(Q38069005)

28 August 2017

1 reference

title

Metabolic changes in cancer: beyond the Warburg effect (English)

1 reference

28 August 2017

Weihua Wu

1

1 reference

28 August 2017

Shimin Zhao

series ordinal

2

1 reference

28 August 2017

publication date

1 January 2013

1 reference

Acta Biochimica et Biophysica Sinica

28 August 2017

published in

1 reference

28 August 2017

volume

45

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

18-26

1 reference

A Positron-Emission Transaxial Tomograph for Nuclear Imaging (PETT)

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

On the Origin of Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Otto Warburg's contributions to current concepts of cancer metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

On respiratory impairment in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Why do cancers have high aerobic glycolysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Fuel feeds function: energy metabolism and the T-cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

A recurrent stop-codon mutation in succinate dehydrogenase subunit B gene in normal peripheral blood and childhood T-cell acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Hypoxia-inducible factors in physiology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Role of iron (II)-2-oxoglutarate-dependent dioxygenases in the generation of hypoxia-induced phosphatidic acid through HIF-1/2 and von Hippel-Lindau-independent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Iron- and 2-oxoglutarate-dependent dioxygenases: an emerging group of molecular targets for nickel toxicity and carcinogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Hypoxia-inducible factors and their roles in energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

21 January 2018

SDH mutations in cancer

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Metabolic regulation of epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

IDH mutation impairs histone demethylation and results in a block to cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Mutations in the D-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Adult manifestation of L-2-hydroxyglutarate dehydrogenase deficiency by a novel mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Human pyruvate kinase M2: a multifunctional protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Pyruvate kinase M2 is a phosphotyrosine-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Modulation of intracellular ROS levels by TIGAR controls autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

A ribonucleotide reductase gene is a transcriptional target of p53 and p73

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

A model for p53-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Activation of p53 by oxidative stress involves platelet-derived growth factor-beta receptor-mediated ataxia telangiectasia mutated (ATM) kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

TIGAR, a p53-inducible regulator of glycolysis and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

p53 regulates mitochondrial respiration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

The interplay between MYC and HIF in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

MYC on the path to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Coordination of glucose and glutamine utilization by an expanded Myc network

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

c-Myc transactivation of LDH-A: implications for tumor metabolism and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

Glycolysis, glutaminolysis and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS104

21 January 2018

Identifiers

DOI

10.1093/ABBS/GMS104

1 reference

release_hlmzcxyvfjbb5i3n64dxesjpeq

28 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hlmzcxyvfjbb5i3n64dxesjpeq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference